Verdad Advisers »

Entrada Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $202k 28k 7.36

More positions owned by Verdad Advisers

Apple (AAPL)
Belite Bio Sponsored Ads (BLTE)
ACADIA Pharmaceuticals (ACAD)
Comcast Corp Cl A (CMCSA)
Chatham Lodging Trust (CLDT)
Tenax Therapeutics Com New (TENX)
Slide Ins Hldgs (SLDE)
Zymeworks Del (ZYME)
AMN Healthcare Services (AMN)
X4 Pharmaceuticals Com New (XFOR)
Versant Media Group Com Cl A (VSNT)
NetScout Systems (NTCT)
Aadi Bioscience (WHWK)
Johnson & Johnson (JNJ)
Contineum Therapeutics Cl A (CTNM)

View all positions for Verdad Advisers

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
Merck & Co
Vanguard Capital Management
MPM Oncology Impact Management
TCG Crossover Management
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
AQR Capital Management
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co

View all funds holding Entrada Therapeutics